The science or data has been presented to the FDA, for a fast...

The science or data has been presented to the FDA, for a fast track designation , the same science has has made us invest our hard earned money in this company. For sure this science hasn’t been changed, actually improved.
what I am Blame is the method the management delivery the news or updates Is shareholders.

someone has already suggested you to spend few hours on the Imugene website, I believe it’s a good idea if you’ll do it.

Imugene is a high risk, speculative stock, with enormous amount of SOI. In this climate of uncertainty traders are making profits, they don’t look at the long term.
that’s why we need a constant interaction with the management.